Cedric Ververken

Cedric Ververken

Cedric Ververken

CEO - Confo Therapeutics

Cedric is CEO and director of Confo Therapeutics. He previously served as Vice President of Business Development at Ablynx and played a key role in landmark deals. Prior to moving to business development, Cedric worked through various R&D functions at Ablynx, first as a scientist in the pharmacology group and later as project manager, leading cross-functional project teams from discovery up to Phase II clinical studies. Cedric has a PhD in bioscience engineering from KU Leuven (Belgium).

 

About Confo Therapeutics

Confo Therapeutics is a private Belgium-based biopharmaceutical company specialized in GPCR drug discovery and development. The company has a unique technology which allows it to discover novel modulators on GPCR targets where other companies/technologies have failed, and is leveraging this platform to build a valuable pipeline of therapeutic candidates in different disease areas. CFTX-1554 is Confo Therapeutics’ first product candidate in pre-clinical development and is designed to address peripheral neuropathic pain while avoiding centrally mediated side effects, such as addiction and sedation. The compound is a novel inhibitor of angiotensin II type 2 receptor (AT2R), a clinically validated target for the treatment of neuropathic pain. Whereas clinical-stage compounds targeting AT2R have failed to progress due to side-effects and/or toxicity concerns, CFTX-1554 more efficiently interacts with the AT2R binding site, resulting in improved drug-like properties. Confo has initiated Phase I-enabling studies and aims to advance CFTX-1554 to clinical development upon successful completion of these studies. Confo was spun out of Vrije Universiteit Brussel (VUB) and VIB in 2015. Supported by international life-science focused investors and led by an experienced team of entrepreneurial professionals and scientists from successful biopharmaceutical companies, Confo Therapeutics benefits from the rich scientific and innovative ecosystem in Belgium.

Flanders.bio Strategic Partners

Flanders.bio Supporting Partners